Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci
The Journal of Antibiotics advance online publication, February 1 2017. doi:10.1038/ja.2017.2
Authors: Zsolt Szűcs, Ilona Bereczki, Magdolna Csávás, Erzsébet Rőth, Anikó Borbás, Gyula Batta, Eszter Ostorházi, Réka Szatmári & Pál Herczegh
from The Journal of Antibiotics - AOP - nature.com science feeds http://ift.tt/2kQeK7o
Aucun commentaire:
Enregistrer un commentaire